Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Pressure Biosciences (OP: PBIO )

0.7500 -0.0999 (-11.75%)
Streaming Delayed Price Updated: 3:49 PM EDT, May 31, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 38,780
Open 0.8100
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.8499
Today's Range 0.7500 - 0.8100
52wk Range 0.7850 - 2.200
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Pressure BioSciences Announces Commercial Availability of Best-in-Class Nano-CBD Topical Spray, Featuring Lightning-Fast Action from PBI's UltraShear Processing
Via ACCESSWIRE
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Achieves Record Financial Results in Q1 2023
Via Investor Brand Network

Performance

YTD
-37.50%
-37.50%
1 Month
-16.74%
-16.74%
3 Month
-58.33%
-58.33%
6 Month
-37.50%
-37.50%
1 Year
-54.82%
-54.82%

More News

Read More
Pressure BioSciences, Inc. Q1 2023 Financial Results Achieve All-Time Quarterly Record
Via ACCESSWIRE
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Eyes New Opportunities, Looks to ‘Watershed’ Year as Focus Groups Report Impressive Results
Via Investor Brand Network
Topics Cannabis
Exposures Cannabis
Pressure BioSciences Announces Expansion into Strategic Manufacturing Facilities with Premier Process Technologies Company, Artisan Industries
Via ACCESSWIRE
Pressure BioSciences, Inc. to Discuss Fiscal Year 2022 Financial Results and Provide 2023 Business Update and Guidance
Via ACCESSWIRE
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Looks to ‘Watershed’ Year as Focus Groups Report Impressive Results, Benefits
Via Investor Brand Network
Topics Cannabis
Exposures Cannabis
Pressure BioScience’s Pressure-Based Tech Is Ready To Spur Innovation And Growth In A Life Sciences Sector In Flux
Via ACCESSWIRE
Extended Consumer Testing Strongly Validates Market Transforming Speed and Dosing Efficiency of Pressure BioSciences UltraShear Processed Nano-THC Oral Spray
Via ACCESSWIRE
Pressure BioScience's Pressure-Based Tech Is Ready To Spur Innovation And Growth In A Life Sciences Sector In Flux
Via Benzinga
Pressure BioSciences and NutraLife Biosciences Renew Partnership for Development and Distribution of Next Generation Nutraceuticals
Via ACCESSWIRE
Pressure BioSciences Reports Fresh Sales Momentum for PBI Agrochem
Via ACCESSWIRE
CBD Oil's Health Benefits Are Reportedly Locked Behind Poor Absorption Rates — This Pressure-Based Tech Company Says It's Found The Key
Via Benzinga
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Announces Rapid Progress on Limited Offering of Exclusive THC Licenses for UST(TM) Platform
Via Investor Brand Network
Pressure BioSciences Updates Rapid Progress on Limited Offering of Exclusive THC Licenses for Revolutionary UltraShear Nanoemulsion Processing Platform
Via ACCESSWIRE
Pressure BioSciences Wins $1.5 Million Contract From CBD Supply MD To Bring A Potent Nano-CBD Topical Spray To Store Shelves In April
Via Benzinga
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Announces Changes to Exclusive UltraShear Nanoemulsion Processing Platform Licenses
Via Investor Brand Network
Topics Cannabis
Exposures Cannabis
Pressure BioSciences Unveils Powerful THC Market Leapfrog Opportunity with Exclusive Licensing of Their Revolutionary UltraShear Nanoemulsion Processing Platform
Via ACCESSWIRE
Conversion Of $10 Million Of Debt Into Equity Bolsters Pressure BioSciences's Balance Sheet, Signals Confidence In Plan To Transition To Profitability
Via Benzinga
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO), Artisan Industries Inc. Enter Strategic Agreement
Via Investor Brand Network
One World Pharma's NBA Legend Isiah Thomas Is Creating CBD-Infused Sports Performance/Recovery Drink, Tapping Power Of Pressure BioSciences Nanoemulsions To Amplify Absorption Rates
Via Benzinga
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Schedules Conference Call, Announces Q4 and FY 2022 Financial Results, 2023 Guidance
Via Investor Brand Network
Pressure BioSciences, Inc. Reports Q4 and FY 2022 Financial Results, Provides Business Update, and Offers Guidance for a Strong 2023
Via ACCESSWIRE
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO), NutraLife Biosciences Partner to Develop, Distribute Next-Generation Nutraceuticals
Via Investor Brand Network
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Eyes Growing Demand for Eco-Friendly Agrochem Products
Via Investor Brand Network
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.